Expression of Membrane Targets for Therapeutics in RET-Positive Non–Small Cell Lung Cancer

In this cohort study of 93 RET⁺ NSCLC samples and 112 RET wild-type controls, mesenchymal epithelial transition factor receptor immunohistochemistry expression was significantly enriched in RET⁺ NSCLC.